Search Results - "Moch, Holger"

Refine Results
  1. 1

    PD‐L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma by Ruf, Melanie, Moch, Holger, Schraml, Peter

    Published in International journal of cancer (15-07-2016)
    “…In our study, we demonstrate that ccRCC cell lines with impaired function of pVHL to degrade HIFα express elevated levels of PD‐L1. In vitro analysis provided…”
    Get full text
    Journal Article
  2. 2

    Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update by Morra, Laura, Moch, Holger

    “…Periostin, also called osteoblast-specific factor 2, is a secreted cell adhesion protein, which shares a homology with the insect cell adhesion molecule…”
    Get full text
    Journal Article
  3. 3

    Endothelial cell infection and endotheliitis in COVID-19 by Varga, Zsuzsanna, Flammer, Andreas J, Steiger, Peter, Haberecker, Martina, Andermatt, Rea, Zinkernagel, Annelies S, Mehra, Mandeep R, Schuepbach, Reto A, Ruschitzka, Frank, Moch, Holger

    Published in The Lancet (British edition) (02-05-2020)
    “…The mechanisms underlying the disproportionate effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on patients with cardiovascular…”
    Get full text
    Journal Article
  4. 4
  5. 5

    A Clearer View of the Molecular Complexity of Clear Cell Renal Cell Carcinoma by Frew, Ian J, Moch, Holger

    Published in Annual review of pathology (01-01-2015)
    “…The von Hippel-Lindau ( VHL ) tumor suppressor gene is mutated as an early event in almost all cases of clear cell renal cell carcinoma (ccRCC), the most…”
    Get full text
    Journal Article
  6. 6

    The single-cell pathology landscape of breast cancer by Jackson, Hartland W., Fischer, Jana R., Zanotelli, Vito R. T., Ali, H. Raza, Mechera, Robert, Soysal, Savas D., Moch, Holger, Muenst, Simone, Varga, Zsuzsanna, Weber, Walter P., Bodenmiller, Bernd

    Published in Nature (London) (27-02-2020)
    “…Single-cell analyses have revealed extensive heterogeneity between and within human tumours 1 – 4 , but complex single-cell phenotypes and their spatial…”
    Get full text
    Journal Article
  7. 7

    Differential PD-1/LAG-3 expression and immune phenotypes in metastatic sites of breast cancer by Sobottka, Bettina, Moch, Holger, Varga, Zsuzsanna

    Published in Breast cancer research : BCR (07-01-2021)
    “…A dual blockade against the novel immune checkpoint inhibitor lymphocyte activation gene-3 (LAG-3) and programmed cell death protein-1 (PD-1) is currently…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Intratumor heterogeneity in hepatocellular carcinoma by Friemel, Juliane, Rechsteiner, Markus, Frick, Lukas, Böhm, Friederike, Struckmann, Kirsten, Egger, Michèle, Moch, Holger, Heikenwalder, Mathias, Weber, Achim

    Published in Clinical cancer research (15-04-2015)
    “…Morphologic intratumor heterogeneity is well known to exist in hepatocellular carcinoma (HCC), but very few systematic analyses of this phenomenon have been…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer by Schödel, Johannes, Grampp, Steffen, Maher, Eamonn R, Moch, Holger, Ratcliffe, Peter J, Russo, Paul, Mole, David R

    Published in European urology (01-04-2016)
    “…Abstract Context Renal cancer is a common urologic malignancy, and therapeutic options for metastatic disease are limited. Most clear cell renal cell…”
    Get full text
    Journal Article
  13. 13

    Biomarker discovery for renal cancer stem cells by Corrò, Claudia, Moch, Holger

    “…Characterised by high intra‐ and inter‐tumor heterogeneity, metastatic renal cell carcinoma (RCC) is resistant to chemo‐ and radiotherapy. Therefore, the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancers by Aimi, Fabio, Moch, Holger, Schraml, Peter, Hottiger, Michael O.

    Published in Modern pathology (01-08-2021)
    “…ADP-ribosylation (ADPR) is a posttranslational modification whose importance in oncology keeps increasing due to frequent use of PARP inhibitors (PARPi) to…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The expression of PD-L1 in salivary gland carcinomas by Vital, Domenic, Ikenberg, Kristian, Moch, Holger, Rössle, Matthias, Huber, Gerhard F.

    Published in Scientific reports (04-09-2019)
    “…Objective was to analyze the role of PD-L1 and its relation to demographic, patho-clinical and outcome parameters in salivary gland carcinoma (SGC) patients…”
    Get full text
    Journal Article
  18. 18

    Mitochondrial Elongation and ROS-Mediated Apoptosis in Prostate Cancer Cells under Therapy with Apalutamide and Complex I Inhibitor by Baumgartner, Valentin, Schaer, Dominik, Moch, Holger, Salemi, Souzan, Eberli, Daniel

    “…Metabolic reprogramming and mitochondrial dynamics are pivotal in prostate cancer (PCa) progression and treatment resistance, making them essential targets for…”
    Get full text
    Journal Article
  19. 19

    Synthetic lethality between BRCA1 deficiency and poly(ADP-ribose) polymerase inhibition is modulated by processing of endogenous oxidative DNA damage by Giovannini, Sara, Weller, Marie-Christine, Repmann, Simone, Moch, Holger, Jiricny, Josef

    Published in Nucleic acids research (26-09-2019)
    “…Poly(ADP-ribose) polymerases (PARPs) facilitate the repair of DNA single-strand breaks (SSBs). When PARPs are inhibited, unrepaired SSBs colliding with…”
    Get full text
    Journal Article
  20. 20